Gürol Gölnül, Çiftci İhsan Hakki, Terizi Huseyin Agah, Atasoy Ali Rıza, Ozbek Ahmet, Köroğlu Mehmet
Department of Physiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
Department of Microbiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
J Microbiol Biotechnol. 2015 Apr;25(4):521-5. doi: 10.4014/jmb.1408.08060.
Bacteremia and sepsis are common causes of morbidity and mortality worldwide, with incorrect or delayed diagnoses being associated with increased mortality. New tests or markers that allow a more rapid and less costly detection of bacteremia and sepsis have been investigated. The aim of this study was to clarify the cutoff value of the neutrophillymphocyte ratio (NLR) according to procalcitonin (PCT) level in the decision-making processes for bacteremia and sepsis. In addition, other white blood cell subgroup parameters, which are assessed in all hospitals, for bacteremia and sepsis were explored. This retrospective study included 1,468 patients with suspected bacteremia and sepsis. Patients were grouped according to the following PCT criteria: levels <0.05 ng/ml (healthy group), 0.05-0.5 ng/ml (local infection group), 0.5-2 ng/ml (systemic infection group), 2-10 ng/ml (sepsis group), and >10 ng/ml (sepsis shock group). One important finding of this study, which will serve as a baseline to measure future progress, is the presence of many gaps in the information on pathogens that constitute a major health risk. In addition, clinical decisions are generally not coordinated, compromising the ability to assess and monitor a situation. This report represents the first study to determine the limits of the use of NLR in the diagnosis of infection or sepsis using a cutoff value of <5 when sufficient exclusion criteria are used.
菌血症和脓毒症是全球发病和死亡的常见原因,诊断错误或延迟与死亡率增加相关。人们已经对能够更快速且成本更低地检测菌血症和脓毒症的新检测方法或标志物进行了研究。本研究的目的是在菌血症和脓毒症的决策过程中,根据降钙素原(PCT)水平阐明中性粒细胞与淋巴细胞比值(NLR)的临界值。此外,还探讨了所有医院用于评估菌血症和脓毒症的其他白细胞亚群参数。这项回顾性研究纳入了1468例疑似菌血症和脓毒症的患者。根据以下PCT标准对患者进行分组:水平<0.05 ng/ml(健康组)、0.05 - 0.5 ng/ml(局部感染组)、0.5 - 2 ng/ml(全身感染组)、2 - 10 ng/ml(脓毒症组)和>10 ng/ml(脓毒症休克组)。本研究的一项重要发现将作为衡量未来进展的基线,即构成主要健康风险的病原体信息存在许多空白。此外,临床决策通常不协调,影响了评估和监测病情的能力。本报告是第一项在使用充分的排除标准时,确定NLR在诊断感染或脓毒症时临界值<5的应用限度的研究。